On July 2023, SOPHiA GENETICS, a leading data-driven medicine company, has announced that the Centre Hospitalier de Bast...
Genenta Science: Temferon™ for the treatment of glioblastoma
Genenta Science, a clinical-stage immuno-oncology company, has received Orphan Drug Designation (ODD) from the European ...